[CDKN2A gene mutation and loss of p16 protein activity in a patient on levodopa presenting sporadic multiple primary melanoma]

scientific article published on 01 October 2006

[CDKN2A gene mutation and loss of p16 protein activity in a patient on levodopa presenting sporadic multiple primary melanoma] is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0151-9638(06)71042-0
P698PubMed publication ID17072193

P50authorJulie CharlesQ63987163
P2093author name stringD Leroux
M-T Leccia
I Templier
B Bressac de Paillerets
M-C Combe
P2860cites workVariants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humansQ24312946
MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutationsQ34020538
Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma.Q34020543
Human pigmentation genes: identification, structure and consequences of polymorphic variationQ34095282
The melanocortin-1 receptor: red hair and beyondQ34439350
The INK4a/ARF locus and melanomaQ35146563
Malignant melanoma and levodopa in Parkinson's disease: causality or coincidence?Q35174508
(Pheo)melanin photosensitizes UVA-induced DNA damage in cultured human melanocytesQ42539144
Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposureQ43073877
Melanoma progression and serum L-dopa/L-tyrosine ratio: a comparison with S100B.Q44078673
CDKN2A and MC1R mutations in patients with sporadic multiple primary melanomaQ47613053
Influence of Genes, Nevi, and Sun Sensitivity on Melanoma Risk in a Family Sample Unselected by Family History and in Melanoma-Prone FamiliesQ56893626
Sporadic multiple primary melanoma cases:CDKN2Agermline mutations with a founder effectQ56893701
Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group [published erratum appears in Hum Mol Genet 1998 May;7(5):941]Q56893811
Melanoma and levodopaQ64891692
Phaeomelanin versus eumelanin as a chemical indicator of ultraviolet sensitivity in fair-skinned subjects at high risk for melanoma: a pilot studyQ74330411
Rarity of CDK4 germline mutations in familial melanomaQ77596261
P433issue10
P304page(s)777-780
P577publication date2006-10-01
P1433published inAnnales de dermatologie et de vénéréologieQ15767313
P1476title[CDKN2A gene mutation and loss of p16 protein activity in a patient on levodopa presenting sporadic multiple primary melanoma]
P478volume133